|
May 9
|
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
|
|
Mar 23
|
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
|
|
Mar 20
|
UPDATE 2-Luxury stocks pressure European equities ahead of Fed verdict
|
|
Mar 20
|
UPDATE 3-Lonza to buy large biologics site from Roche in US for $1.2 bln
|
|
Mar 20
|
Lonza to buy large biologics site from Roche in US for $1.2 billion
|
|
Feb 10
|
30 Most Valuable Drug Companies in 2024
|
|
Oct 26
|
Individual investors who have a significant stake must be disappointed along with institutions after Lonza Group AG's (VTX:LONN) market cap dropped by CHF2.2b
|
|
Aug 11
|
Is Lonza Group AG (VTX:LONN) Worth CHF498 Based On Its Intrinsic Value?
|
|
Jun 26
|
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies
|
|
Jun 22
|
Q4 2023 Avid Bioservices Inc Earnings Call
|
|
May 19
|
Individual investors account for 56% of Lonza Group AG's (VTX:LONN) ownership, while institutions account for 44%
|